Literature DB >> 18641925

Complement and cutaneous autoimmune blistering diseases.

Elizabeth Lessey1, Ning Li, Luis Diaz, Zhi Liu.   

Abstract

Cutaneous autoimmune blistering diseases are associated with tissue injury and fluid accumulation within the skin. The initial trigger for the organ-specific damage is autoantibodies targeting skin autoantigens, which are involved in cell-cell or cell-matrix adhesion in the skin. Pemphigus autoantibodies bind to desmosomal antigens and cause intraepidermal blisters, while pemphigoid autoantibodies interact with hemidesmosomal or hemidesmosome-associated antigens and lead to dermal-epidermal junction separation. Local complement activation is a common feature for these skin blistering diseases and some complement components are readily detected in the lesional skin and blister fluids. This review summarizes the current knowledge on the role the complement system in skin blister formation. Characterization of the pathogenically relevant complement cascade and relative contribution of different pathways into complement activation provides new insights of disease pathology and may help develop better therapeutic strategies for these potentially fatal cutaneous blistering disorders.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641925     DOI: 10.1007/s12026-008-8028-y

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  62 in total

1.  Basement zone antibodies in bullous pemphigoid.

Authors:  R E Jordon; E H Beutner; E Witebsky; G Blumental; W L Hale; W F Lever
Journal:  JAMA       Date:  1967-05-29       Impact factor: 56.272

Review 2.  Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion.

Authors:  J R Stanley
Journal:  Adv Immunol       Date:  1993       Impact factor: 3.543

3.  Isolation of a human epidermal cDNA corresponding to the 180-kD autoantigen recognized by bullous pemphigoid and herpes gestationis sera. Immunolocalization of this protein to the hemidesmosome.

Authors:  L A Diaz; H Ratrie; W S Saunders; S Futamura; H L Squiquera; G J Anhalt; G J Giudice
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

4.  Induction of complement-fixing autoantibodies against type VII collagen results in subepidermal blistering in mice.

Authors:  Cassian Sitaru; Mircea T Chiriac; Sidonia Mihai; Jürgen Büning; Andreas Gebert; Akira Ishiko; Detlef Zillikens
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

5.  Role of different pathways of the complement cascade in experimental bullous pemphigoid.

Authors:  Kelly C Nelson; Minglang Zhao; Pamela R Schroeder; Ning Li; Rick A Wetsel; Luis A Diaz; Zhi Liu
Journal:  J Clin Invest       Date:  2006-10-05       Impact factor: 14.808

6.  The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita.

Authors:  Sidonia Mihai; Mircea T Chiriac; Kazue Takahashi; Joshua M Thurman; V Michael Holers; Detlef Zillikens; Marina Botto; Cassian Sitaru
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

7.  Epitope mapping of type VII collagen. Identification of discrete peptide sequences recognized by sera from patients with acquired epidermolysis bullosa.

Authors:  J C Lapiere; D T Woodley; M G Parente; T Iwasaki; K C Wynn; A M Christiano; J Uitto
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

8.  Induction of epidermolysis bullosa acquisita in mice by passive transfer of autoantibodies from patients.

Authors:  David T Woodley; Ramin Ram; Arvin Doostan; Pubali Bandyopadhyay; Yi Huang; Jennifer Remington; Yingping Hou; Douglas R Keene; Zhi Liu; Mei Chen
Journal:  J Invest Dermatol       Date:  2006-06       Impact factor: 8.551

9.  Differences in direct immunofluorescence staining patterns in epidermolysis bullosa acquisita and bullous pemphigoid.

Authors:  B R Smoller; D T Woodley
Journal:  J Am Acad Dermatol       Date:  1992-11       Impact factor: 11.527

Review 10.  The role of complement in the development of systemic lupus erythematosus.

Authors:  Anthony P Manderson; Marina Botto; Mark J Walport
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

View more
  10 in total

1.  Classical complement pathway activation in the nasal tissue of patients with chronic rhinosinusitis.

Authors:  Griet A Van Roey; Christopher C Vanison; Jeffanie Wu; Julia H Huang; Lydia A Suh; Roderick G Carter; James E Norton; Stephanie Shintani-Smith; David B Conley; Kevin C Welch; Anju T Peters; Leslie C Grammer; Kathleen E Harris; Kathryn E Hulse; Atsushi Kato; Whitney W Stevens; Robert C Kern; Robert P Schleimer; Bruce K Tan
Journal:  J Allergy Clin Immunol       Date:  2016-12-12       Impact factor: 10.793

2.  Dynamics of the interaction of human IgG subtype immune complexes with cells expressing R and H allelic forms of a low-affinity Fc gamma receptor CD32A.

Authors:  Rangaiah Shashidharamurthy; Fang Zhang; Aaron Amano; Aparna Kamat; Ravichandran Panchanathan; Daniel Ezekwudo; Cheng Zhu; Periasamy Selvaraj
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

Review 3.  Complement system in dermatological diseases - fire under the skin.

Authors:  Jaana Panelius; Seppo Meri
Journal:  Front Med (Lausanne)       Date:  2015-01-29

4.  Dysregulation of mCD46 and sCD46 contribute to the pathogenesis of bullous pemphigoid.

Authors:  Pei Qiao; Erle Dang; Tianyu Cao; Hui Fang; Jieyu Zhang; Hongjiang Qiao; Gang Wang
Journal:  Sci Rep       Date:  2017-03-10       Impact factor: 4.379

Review 5.  Complement Activation in Inflammatory Skin Diseases.

Authors:  Jenny Giang; Marc A J Seelen; Martijn B A van Doorn; Robert Rissmann; Errol P Prens; Jeffrey Damman
Journal:  Front Immunol       Date:  2018-04-16       Impact factor: 7.561

6.  Decreased expression levels of complement regulator CD55 contribute to the development of bullous pemphigoid.

Authors:  Pei Qiao; Er-Le Dang; Hui Fang; Jie-Yu Zhang; Bing Li; Sheng-Xian Shen; Yi-Xin Luo; Jie Lei; Shuai Shao; Hong-Jiang Qiao; Gang Wang
Journal:  Oncotarget       Date:  2017-09-23

Review 7.  Role of Regulatory Immune Cells and Molecules in Autoimmune Bullous Dermatoses.

Authors:  Tianyu Cao; Shuai Shao; Hui Fang; Bing Li; Gang Wang
Journal:  Front Immunol       Date:  2019-08-02       Impact factor: 7.561

Review 8.  The relevance of complement in pemphigoid diseases: A critical appraisal.

Authors:  Cristian Papara; Christian M Karsten; Hideyuki Ujiie; Enno Schmidt; Leon F Schmidt-Jiménez; Adrian Baican; Patricia C Freire; Kentaro Izumi; Katja Bieber; Matthias Peipp; Admar Verschoor; Ralf J Ludwig; Jörg Köhl; Detlef Zillikens; Christoph M Hammers
Journal:  Front Immunol       Date:  2022-08-16       Impact factor: 8.786

9.  Pemphigus vulgaris autoantibody profiling by proteomic technique.

Authors:  Mina Kalantari-Dehaghi; Grant J Anhalt; Michael J Camilleri; Alex I Chernyavsky; Sookhee Chun; Philip L Felgner; Algis Jasinskas; Kristin M Leiferman; Li Liang; Steve Marchenko; Rie Nakajima-Sasaki; Mark R Pittelkow; John J Zone; Sergei A Grando
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

Review 10.  Complement, a target for therapy in inflammatory and degenerative diseases.

Authors:  B Paul Morgan; Claire L Harris
Journal:  Nat Rev Drug Discov       Date:  2015-10-23       Impact factor: 112.288

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.